Date: 25/06/2008

Debiotech and ST micro successfully develop a prototype of automatic insulin pump

Diabetic patients are gifted with new technology where an insulin pump works very closely to a pancreas. Debiotech, a medical device company in partnership with leading semiconductor device manufacturer ST Microelectronics has successfully tested highly miniaturized insulin pump. Debiotech has very effectively used ST Micro’s Micro Electro Mechanical System (MEMS) technology in building silicon based microfluidic devices.
The size of the nanopump is so small it can be worn as a small patch on the skin. The cost of the device is priced low compared to other insulin pumps in the market.

This device has undergone all the key tests and Debiotech has started volume manufacturing.

This technology will significantly automate the treatment of various diseases by controlled delivary of any drug to the patient body.